data_2PP
#
_chem_comp.id                                        2PP
_chem_comp.name                                      "2-PROPYL-PENTANOIC ACID"
_chem_comp.type                                      NON-POLYMER
_chem_comp.pdbx_type                                 HETAIN
_chem_comp.formula                                   "C8 H16 O2"
_chem_comp.mon_nstd_parent_comp_id                   ?
_chem_comp.pdbx_synonyms                             ?
_chem_comp.pdbx_formal_charge                        0
_chem_comp.pdbx_initial_date                         1999-07-08
_chem_comp.pdbx_modified_date                        2011-06-04
_chem_comp.pdbx_ambiguous_flag                       N
_chem_comp.pdbx_release_status                       REL
_chem_comp.pdbx_replaced_by                          ?
_chem_comp.pdbx_replaces                             ?
_chem_comp.formula_weight                            144.211
_chem_comp.one_letter_code                           ?
_chem_comp.three_letter_code                         2PP
_chem_comp.pdbx_model_coordinates_details            ?
_chem_comp.pdbx_model_coordinates_missing_flag       N
_chem_comp.pdbx_ideal_coordinates_details            ?
_chem_comp.pdbx_ideal_coordinates_missing_flag       N
_chem_comp.pdbx_model_coordinates_db_code            1DIT
_chem_comp.pdbx_subcomponent_list                    ?
_chem_comp.pdbx_processing_site                      RCSB

#
loop_
_chem_comp_atom.comp_id                        
_chem_comp_atom.atom_id                        
_chem_comp_atom.alt_atom_id                    
_chem_comp_atom.type_symbol                    
_chem_comp_atom.charge                         
_chem_comp_atom.pdbx_align                     
_chem_comp_atom.pdbx_aromatic_flag             
_chem_comp_atom.pdbx_leaving_atom_flag         
_chem_comp_atom.pdbx_stereo_config             
_chem_comp_atom.model_Cartn_x                  
_chem_comp_atom.model_Cartn_y                  
_chem_comp_atom.model_Cartn_z                  
_chem_comp_atom.pdbx_model_Cartn_x_ideal       
_chem_comp_atom.pdbx_model_Cartn_y_ideal       
_chem_comp_atom.pdbx_model_Cartn_z_ideal       
_chem_comp_atom.pdbx_component_atom_id         
_chem_comp_atom.pdbx_component_comp_id         
_chem_comp_atom.pdbx_ordinal                   
2PP     C1     C1 C 0 1 N N N 18.142 -17.002 24.699  1.131  0.020 -0.007     C1 2PP  1
2PP     C2     C2 C 0 1 N N N 18.896 -17.085 26.059 -0.320 -0.379  0.016     C2 2PP  2
2PP     C3     C3 C 0 1 N N N 19.534 -15.826 26.532 -0.974  0.150  1.294     C3 2PP  3
2PP     C4     C4 C 0 1 N N N 20.007 -14.767 25.532 -0.263 -0.439  2.513     C4 2PP  4
2PP     C5     C5 C 0 1 N N N 21.133 -13.955 26.111 -0.917  0.090  3.791     C5 2PP  5
2PP  "C1'"  "C1'" C 0 1 N N N 17.952 -17.612 27.143 -1.032  0.210 -1.203  "C1'" 2PP  6
2PP  "C2'"  "C2'" C 0 1 N N N 17.126 -18.739 26.502 -0.378 -0.319 -2.480  "C2'" 2PP  7
2PP  "C3'"  "C3'" C 0 1 N N N 17.584 -20.116 26.873 -1.089  0.271 -3.700  "C3'" 2PP  8
2PP     O1     O1 O 0 1 N N N 18.858 -17.468 23.712  1.596  0.662  0.904     O1 2PP  9
2PP     O2     O2 O 0 1 N Y N 16.974 -16.498 24.303  1.909 -0.337 -1.040     O2 2PP 10
2PP     H2     H2 H 0 1 N N N 19.743 -17.784 25.866 -0.399 -1.466 -0.008     H2 2PP 11
2PP    H31    1H3 H 0 1 N N N 18.843 -15.336 27.257 -2.025 -0.138  1.311    H31 2PP 12
2PP    H32    2H3 H 0 1 N N N 20.395 -16.096 27.186 -0.896  1.237  1.318    H32 2PP 13
2PP    H41    1H4 H 0 1 N N N 20.285 -15.219 24.551  0.787 -0.150  2.496    H41 2PP 14
2PP    H42    2H4 H 0 1 N N N 19.166 -14.120 25.185 -0.342 -1.526  2.489    H42 2PP 15
2PP    H51    1H5 H 0 1 N N N 21.477 -13.184 25.382 -0.411 -0.330  4.659    H51 2PP 16
2PP    H52    2H5 H 0 1 N N N 20.854 -13.502 27.091 -0.839  1.177  3.815    H52 2PP 17
2PP    H53    3H5 H 0 1 N N N 21.973 -14.601 26.457 -1.968 -0.198  3.808    H53 2PP 18
2PP "H1'1" "1H1'" H 0 0 N N N 18.482 -17.928 28.071 -2.082 -0.078 -1.185 "H1'1" 2PP 19
2PP "H1'2" "2H1'" H 0 0 N N N 17.324 -16.814 27.604 -0.953  1.297 -1.178 "H1'2" 2PP 20
2PP "H2'1" "1H2'" H 0 0 N N N 16.042 -18.610 26.733  0.672 -0.030 -2.497 "H2'1" 2PP 21
2PP "H2'2" "2H2'" H 0 0 N N N 17.096 -18.621 25.393 -0.456 -1.405 -2.505 "H2'2" 2PP 22
2PP "H3'1" "1H3'" H 0 0 N N N 16.984 -20.933 26.408 -0.623 -0.106 -4.610 "H3'1" 2PP 23
2PP "H3'2" "2H3'" H 0 0 N N N 18.667 -20.244 26.641 -2.140 -0.017 -3.683 "H3'2" 2PP 24
2PP "H3'3" "3H3'" H 0 0 N N N 17.613 -20.233 27.981 -1.010  1.358 -3.675 "H3'3" 2PP 25
2PP    HO2    HO2 H 0 1 N N N 16.514 -16.447 23.473  2.842 -0.081 -1.056    HO2 2PP 26
#
loop_
_chem_comp_bond.comp_id                  
_chem_comp_bond.atom_id_1                
_chem_comp_bond.atom_id_2                
_chem_comp_bond.value_order              
_chem_comp_bond.pdbx_aromatic_flag       
_chem_comp_bond.pdbx_stereo_config       
_chem_comp_bond.pdbx_ordinal             
2PP    C1     C2 SING N N  1
2PP    C1     O1 DOUB N N  2
2PP    C1     O2 SING N N  3
2PP    C2     C3 SING N N  4
2PP    C2  "C1'" SING N N  5
2PP    C2     H2 SING N N  6
2PP    C3     C4 SING N N  7
2PP    C3    H31 SING N N  8
2PP    C3    H32 SING N N  9
2PP    C4     C5 SING N N 10
2PP    C4    H41 SING N N 11
2PP    C4    H42 SING N N 12
2PP    C5    H51 SING N N 13
2PP    C5    H52 SING N N 14
2PP    C5    H53 SING N N 15
2PP "C1'"  "C2'" SING N N 16
2PP "C1'" "H1'1" SING N N 17
2PP "C1'" "H1'2" SING N N 18
2PP "C2'"  "C3'" SING N N 19
2PP "C2'" "H2'1" SING N N 20
2PP "C2'" "H2'2" SING N N 21
2PP "C3'" "H3'1" SING N N 22
2PP "C3'" "H3'2" SING N N 23
2PP "C3'" "H3'3" SING N N 24
2PP    O2    HO2 SING N N 25
#
loop_
_pdbx_chem_comp_descriptor.comp_id               
_pdbx_chem_comp_descriptor.type                  
_pdbx_chem_comp_descriptor.program               
_pdbx_chem_comp_descriptor.program_version       
_pdbx_chem_comp_descriptor.descriptor            
2PP           SMILES              ACDLabs 10.04                                                 O=C(O)C(CCC)CCC
2PP SMILES_CANONICAL               CACTVS 3.341                                                 CCCC(CCC)C(O)=O
2PP           SMILES               CACTVS 3.341                                                 CCCC(CCC)C(O)=O
2PP SMILES_CANONICAL "OpenEye OEToolkits" 1.5.0                                                 CCCC(CCC)C(=O)O
2PP           SMILES "OpenEye OEToolkits" 1.5.0                                                 CCCC(CCC)C(=O)O
2PP            InChI                InChI  1.03 InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
2PP         InChIKey                InChI  1.03                                     NIJJYAXOARWZEE-UHFFFAOYSA-N
#
loop_
_pdbx_chem_comp_identifier.comp_id               
_pdbx_chem_comp_identifier.type                  
_pdbx_chem_comp_identifier.program               
_pdbx_chem_comp_identifier.program_version       
_pdbx_chem_comp_identifier.identifier            
2PP "SYSTEMATIC NAME"              ACDLabs 10.04 "2-propylpentanoic acid"
2PP "SYSTEMATIC NAME" "OpenEye OEToolkits" 1.5.0 "2-propylpentanoic acid"
#
loop_
_pdbx_chem_comp_audit.comp_id               
_pdbx_chem_comp_audit.action_type           
_pdbx_chem_comp_audit.date                  
_pdbx_chem_comp_audit.processing_site       
_pdbx_chem_comp_audit.annotator             
_pdbx_chem_comp_audit.details               
2PP  "Create component" 1999-07-08 RCSB ? ?
2PP "Modify descriptor" 2011-06-04 RCSB ? ?
#
_pdbe_chem_comp_drugbank_details.comp_id                   2PP
_pdbe_chem_comp_drugbank_details.drugbank_id               DB00313
_pdbe_chem_comp_drugbank_details.type                      "small molecule"
_pdbe_chem_comp_drugbank_details.name                      "Valproic Acid"
_pdbe_chem_comp_drugbank_details.description               "Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects of khelline when he found that all of his samples, dissolved in valproic acid, exerted a similar degree of anticonvulsive activity. It first received approval on February 28, 1978 from the FDA under the trade name Depakene.[L6190]  Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. It is currently a compound of interest in the field of oncology for its anti-proliferative effects and is the subject of many clinical trials in a variety of cancer types."
_pdbe_chem_comp_drugbank_details.cas_number                99-66-1
_pdbe_chem_comp_drugbank_details.mechanism_of_action       "The exact mechanisms by which valproate exerts it's effects on epilepsy, migraine headaches, and bipolar disorder are unknown however several pathways exist which may contribute to the drug's action.  Valproate is known to inhibit succinic semialdehyde dehydrogenase.[A177991] This inhibition results in an increase in succinic semialdehyde which acts as an inhibitor of GABA transaminase ultimately reducing GABA metabolism and increasing GABAergic neurotransmission. As GABA is an inhibitory neurotransmitter, this increase results in increased inhibitory activity.[A457] A possible secondary contributor to cortical inhibition is a direct suppression of voltage gated sodium channel activity and indirect suppression through effects on GABA.  It has also been suggested that valproate impacts the extracellular signal-related kinase pathway (ERK).[A457] These effects appear to be dependent on mitogen-activated protein kinase (MEK) and result in the phosphorylation of ERK1/2. This activation increases expression of several downstream targets including ELK-1 with subsequent increases in c-fos, growth cone-associated protein-43 which contributes to neural plasticity, B-cell lymphoma/leukaemia-2 which is an anti-apoptotic protein, and brain-derived neurotrophic factor (BDNF) which is also involved in neural plasticity and growth. Increased neurogenesis and neurite growth due to valproate are attributed to the effects of this pathway. An additional downstream effect of increased BDNF expression appears to be an increase in GABA<sub>A</sub> receptors which contribute further to increased GABAergic activity.[A177997]  Valproate exerts a non-competitive indirect inhibitory effect on myo-inosital-1-phophate synthetase.[A178000] This results in reduced de novo synthesis of inositol monophosphatase and subsequent inositol depletion. It is unknown how this contributed to valproate's effects on bipolar disorder but [lithium] is known to exert a similar inositol-depleting effect.[A178003] Valproate exposure also appears to produce down-regulation of protein kinase C proteins (PKC)-α and -ε which are potentially related to bipolar disorder as PKC is unregulated in the frontal cortex of bipolar patients. This is further supported by a similar reduction in PKC with lithium.[A178015] The inhibition of the PKC pathway may also be a contributor to migraine prophylaxis.[A178018] Myristoylated alanine-rich C kinase substrate, a PKC substrate, is also downregulated by valproate and may contribute to changes in synaptic remodeling through effects on the cytoskeleton.[A178021]  Valproate also appears to impact fatty acid metabolism.[A457] Less incorporation of fatty acid substrates in sterols and glycerolipids is thought to impact membrane fluidity and result in increased action potential threshold potentially contributing to valproate's antiepileptic action.[A178024] Valproate has been found to be a non-competitive direct inhibitor of brain microsomal long-chain fatty acyl-CoA synthetase.[A14708] Inhibition of this enzyme decreases available arichidonyl-CoA, a substrate in the production of inflammatory prostaglandins. It is thought that this may be a mechanism behind valproate's efficacy in migraine prophylaxis as migraines are routinely treated with non-steroidal anti-inflammatory drugs which also inhibit prostaglandin production.  Finally, valproate acts as a direct histone deactylase (HDAC) inhibitor.[A178030] Hyperacetylation of lysine residues on histones promoted DNA relaxation and allows for increased gene transcription. The scope of valproate's genomic effects is wide with 461 genes being up or down-regulated.[A178027] The relation of these genomic effects to therapeutic value is not fully characterized however H3 and H4 hyperacetylation correlates with improvement of symptoms in bipolar patients.[A178033] Histone hyperacetylation at the BDNF gene, increasing BDNF expression, post-seizure is known to occur and is thought to be a neuroprotective mechanism which valproate may strengthen or prolong.[A178036] H3 hyperacetylation is associated with a reduction in glyceraldehyde-3-phosphate dehydrogenase, a pro-apoptotic enzyme, contributing further to valproate's neuroprotective effects.[A11814]"

#
_pdbe_chem_comp_drugbank_classification.comp_id           2PP
_pdbe_chem_comp_drugbank_classification.drugbank_id       DB00313
_pdbe_chem_comp_drugbank_classification.parent            "Methyl-branched fatty acids"
_pdbe_chem_comp_drugbank_classification.kingdom           "Organic compounds"
_pdbe_chem_comp_drugbank_classification.class             "Fatty Acyls"
_pdbe_chem_comp_drugbank_classification.superclass        "Lipids and lipid-like molecules"
_pdbe_chem_comp_drugbank_classification.description       "This compound belongs to the class of organic compounds known as methyl-branched fatty acids. These are fatty acids with an acyl chain that has a methyl branch. Usually, they are saturated and contain only one or more methyl group. However, branches other than methyl may be present."

#
loop_
_pdbe_chem_comp_drugbank_targets.comp_id                        
_pdbe_chem_comp_drugbank_targets.drugbank_id                    
_pdbe_chem_comp_drugbank_targets.name                           
_pdbe_chem_comp_drugbank_targets.organism                       
_pdbe_chem_comp_drugbank_targets.uniprot_id                     
_pdbe_chem_comp_drugbank_targets.pharmacologically_active       
_pdbe_chem_comp_drugbank_targets.ordinal                        
2PP DB00313 "Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial" Humans P45954 unknown  1
2PP DB00313                                               "Histone deacetylase 9" Humans Q9UKV0     yes  2
2PP DB00313                         "2-oxoglutarate dehydrogenase, mitochondrial" Humans Q02218 unknown  3
2PP DB00313                 "Succinate-semialdehyde dehydrogenase, mitochondrial" Humans P51649 unknown  4
2PP DB00313                         "Sodium channel protein type 1 subunit alpha" Humans P35498 unknown  5
2PP DB00313                        "Sodium channel protein type 10 subunit alpha" Humans Q9Y5Y9 unknown  6
2PP DB00313                        "Sodium channel protein type 11 subunit alpha" Humans Q9UI33 unknown  7
2PP DB00313                         "Sodium channel protein type 2 subunit alpha" Humans Q99250 unknown  8
2PP DB00313                         "Sodium channel protein type 3 subunit alpha" Humans Q9NY46 unknown  9
2PP DB00313                         "Sodium channel protein type 4 subunit alpha" Humans P35499 unknown 10
2PP DB00313                         "Sodium channel protein type 5 subunit alpha" Humans Q14524 unknown 11
2PP DB00313                         "Sodium channel protein type 7 subunit alpha" Humans Q01118 unknown 12
2PP DB00313                         "Sodium channel protein type 8 subunit alpha" Humans Q9UQD0 unknown 13
2PP DB00313                         "Sodium channel protein type 9 subunit alpha" Humans Q15858 unknown 14
2PP DB00313                                       "Sodium channel subunit beta-1" Humans Q07699 unknown 15
2PP DB00313                                       "Sodium channel subunit beta-2" Humans O60939 unknown 16
2PP DB00313                                       "Sodium channel subunit beta-3" Humans Q9NY72 unknown 17
2PP DB00313                                       "Sodium channel subunit beta-4" Humans Q8IWT1 unknown 18
2PP DB00313                                               "Histone deacetylase 2" Humans Q92769 unknown 19
2PP DB00313                    "Peroxisome proliferator-activated receptor alpha" Humans Q07869 unknown 20
2PP DB00313                    "Peroxisome proliferator-activated receptor delta" Humans Q03181 unknown 21
2PP DB00313                    "Peroxisome proliferator-activated receptor gamma" Humans P37231 unknown 22
#
loop_
_pdbx_chem_comp_synonyms.comp_id          
_pdbx_chem_comp_synonyms.name             
_pdbx_chem_comp_synonyms.provenance       
2PP                     Stavzor   ChEMBL
2PP                       44089   ChEMBL
2PP                    Depakene   ChEMBL
2PP                    Depakote   ChEMBL
2PP                    Convulex   ChEMBL
2PP             "Valproic Acid"   ChEMBL
2PP             "Valproic acid"   ChEMBL
2PP "2-n-propyl-n-valeric acid" DrugBank
2PP   "2-propyl-pentanoic acid" DrugBank
2PP    "2-Propylpentanoic Acid" DrugBank
2PP      "2-Propylvaleric Acid" DrugBank
2PP  "4-heptanecarboxylic acid" DrugBank
2PP    "di-n-propylacetic acid" DrugBank
2PP       "Dipropylacetic acid" DrugBank
2PP                         DPA DrugBank
2PP                       n-DPA DrugBank
2PP                   Valproate DrugBank
2PP             "Valproic Acid" DrugBank
2PP                         VPA DrugBank
#
loop_
_software.name              
_software.version           
_software.description       
       rdkit 2019.03.2                                      "Core functionality."
pdbeccdutils     0.5.2 "Wrapper to provide 2D templates and molecular fragments."
#
loop_
_pdbe_chem_comp_atom_depiction.comp_id             
_pdbe_chem_comp_atom_depiction.atom_id             
_pdbe_chem_comp_atom_depiction.element             
_pdbe_chem_comp_atom_depiction.model_Cartn_x       
_pdbe_chem_comp_atom_depiction.model_Cartn_y       
_pdbe_chem_comp_atom_depiction.pdbx_ordinal        
2PP    C1 C 8.196  1.500  1
2PP    C2 C 6.897  0.750  2
2PP    C3 C 5.598  1.500  3
2PP    C4 C 4.299  0.750  4
2PP    C5 C 3.000  1.500  5
2PP "C1'" C 6.897 -0.750  6
2PP "C2'" C 5.598 -1.500  7
2PP "C3'" C 5.598 -3.000  8
2PP    O1 O 9.495  0.750  9
2PP    O2 O 8.196  3.000 10
#
loop_
_pdbe_chem_comp_bond_depiction.comp_id            
_pdbe_chem_comp_bond_depiction.atom_id_1          
_pdbe_chem_comp_bond_depiction.atom_id_2          
_pdbe_chem_comp_bond_depiction.value_order        
_pdbe_chem_comp_bond_depiction.bond_dir           
_pdbe_chem_comp_bond_depiction.pdbx_ordinal       
2PP    C1    C2 SINGLE NONE 1
2PP    C1    O1 DOUBLE NONE 2
2PP    C1    O2 SINGLE NONE 3
2PP    C2    C3 SINGLE NONE 4
2PP    C2 "C1'" SINGLE NONE 5
2PP    C3    C4 SINGLE NONE 6
2PP    C4    C5 SINGLE NONE 7
2PP "C1'" "C2'" SINGLE NONE 8
2PP "C2'" "C3'" SINGLE NONE 9
#
_pdbe_chem_comp_rdkit_properties.comp_id                               2PP
_pdbe_chem_comp_rdkit_properties.exactmw                               144.115
_pdbe_chem_comp_rdkit_properties.lipinskiHBA                           2
_pdbe_chem_comp_rdkit_properties.lipinskiHBD                           1
_pdbe_chem_comp_rdkit_properties.NumRotatableBonds                     7
_pdbe_chem_comp_rdkit_properties.NumHBD                                1
_pdbe_chem_comp_rdkit_properties.NumHBA                                2
_pdbe_chem_comp_rdkit_properties.NumHeteroatoms                        2
_pdbe_chem_comp_rdkit_properties.NumAmideBonds                         0
_pdbe_chem_comp_rdkit_properties.FractionCSP3                          0.875
_pdbe_chem_comp_rdkit_properties.NumRings                              0
_pdbe_chem_comp_rdkit_properties.NumAromaticRings                      0
_pdbe_chem_comp_rdkit_properties.NumAliphaticRings                     0
_pdbe_chem_comp_rdkit_properties.NumSaturatedRings                     0
_pdbe_chem_comp_rdkit_properties.NumHeterocycles                       0
_pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles               0
_pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles              0
_pdbe_chem_comp_rdkit_properties.NumSpiroAtoms                         0
_pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms                    0
_pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters                  0
_pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters       0
_pdbe_chem_comp_rdkit_properties.labuteASA                             84.816
_pdbe_chem_comp_rdkit_properties.tpsa                                  37.300
_pdbe_chem_comp_rdkit_properties.CrippenClogP                          2.287
_pdbe_chem_comp_rdkit_properties.CrippenMR                             40.942
_pdbe_chem_comp_rdkit_properties.NumHeavyAtoms                         10

#
loop_
_pdbe_chem_comp_external_mappings.comp_id           
_pdbe_chem_comp_external_mappings.source            
_pdbe_chem_comp_external_mappings.resource          
_pdbe_chem_comp_external_mappings.resource_id       
2PP UniChem        ChEMBL        CHEMBL109
2PP UniChem      DrugBank          DB00313
2PP UniChem "KEGG LIGAND"           C07185
2PP UniChem         ChEBI            39867
2PP UniChem          ZINC ZINC000003008621
2PP UniChem    NMRShiftDB         20200678
2PP UniChem     BindingDb         50003616
2PP UniChem        BRENDA           104648
2PP UniChem        BRENDA           107471
2PP UniChem        BRENDA             2424
#
loop_
_pdbe_chem_comp_rdkit_conformer.comp_id             
_pdbe_chem_comp_rdkit_conformer.atom_id             
_pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit       
_pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit       
_pdbe_chem_comp_rdkit_conformer.rdkit_method        
_pdbe_chem_comp_rdkit_conformer.rdkit_ordinal       
2PP     C1 -0.005  1.679 -0.897 ETKDGv2  1
2PP     C2  0.013  0.772  0.313 ETKDGv2  2
2PP     C3  1.437  0.234  0.580 ETKDGv2  3
2PP     C4  1.984 -0.684 -0.526 ETKDGv2  4
2PP     C5  3.406 -1.136 -0.209 ETKDGv2  5
2PP  "C1'" -1.037 -0.361  0.225 ETKDGv2  6
2PP  "C2'" -2.474  0.179  0.301 ETKDGv2  7
2PP  "C3'" -3.493 -0.955  0.236 ETKDGv2  8
2PP     O1 -0.243  1.214 -2.044 ETKDGv2  9
2PP     O2  0.291  3.032 -0.764 ETKDGv2 10
2PP     H2 -0.252  1.394  1.198 ETKDGv2 11
2PP    H31  2.125  1.100  0.707 ETKDGv2 12
2PP    H32  1.434 -0.322  1.544 ETKDGv2 13
2PP    H41  1.345 -1.587 -0.625 ETKDGv2 14
2PP    H42  1.995 -0.149 -1.499 ETKDGv2 15
2PP    H51  4.083 -0.258 -0.134 ETKDGv2 16
2PP    H52  3.428 -1.699  0.749 ETKDGv2 17
2PP    H53  3.775 -1.800 -1.019 ETKDGv2 18
2PP "H1'1" -0.910 -0.933 -0.720 ETKDGv2 19
2PP "H1'2" -0.881 -1.065  1.072 ETKDGv2 20
2PP "H2'1" -2.663  0.876 -0.544 ETKDGv2 21
2PP "H2'2" -2.616  0.735  1.253 ETKDGv2 22
2PP "H3'1" -4.519 -0.536  0.293 ETKDGv2 23
2PP "H3'2" -3.389 -1.512 -0.719 ETKDGv2 24
2PP "H3'3" -3.347 -1.654  1.087 ETKDGv2 25
2PP    HO2  0.514  3.435  0.139 ETKDGv2 26
#
